Borderline personality disorder stigma: Examining the effects of diagnostic disclosure, behavior, and gender as sources of stigma in the general population.
Personality Disorders: Theory, Research, and Treatment · 2024
DOI: 10.1037/per0000672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Personality Disorders: Theory, Research, and Treatment, 2024. Verfasst von Maya E Amestoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Clinical Science, University of Toronto Scarborough. Hauptthemen laut MEDLINE: Borderline Personality Disorder, Social Stigma. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Gefördert von: Social Sciences and Humanities Research Council of Canada.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychological Clinical Science, University of Toronto Scarborough.
ORCID-Profile: Maya E Amestoy
Förderung
- Social Sciences and Humanities Research Council of Canada
Zitieren
APA
Amestoy, M. E., Best, M. W., Ruocco, A. C., & Uliaszek, A. A. (2024). Borderline personality disorder stigma: Examining the effects of diagnostic disclosure, behavior, and gender as sources of stigma in the general population. Personality Disorders: Theory, Research, and Treatment. https://doi.org/10.1037/per0000672
Vancouver
Amestoy ME, Best MW, Ruocco AC, Uliaszek AA. Borderline personality disorder stigma: Examining the effects of diagnostic disclosure, behavior, and gender as sources of stigma in the general population. Personality Disorders: Theory, Research, and Treatment. 2024. doi:10.1037/per0000672
BibTeX
@article{Amestoy2024,
author = {Amestoy, Maya E and Best, Michael W and Ruocco, Anthony C and Uliaszek, Amanda A},
title = {Borderline personality disorder stigma: Examining the effects of diagnostic disclosure, behavior, and gender as sources of stigma in the general population},
journal = {Personality Disorders: Theory, Research, and Treatment},
year = {2024},
doi = {10.1037/per0000672}
}
EUVIMED